Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Auditor change
Director departure
Appointed director
ARRHYTHMIA RESEARCH TECHNOLOGY INC (MICR) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/16/2020 8-K Quarterly results
11/13/2019 8-K Quarterly results
08/16/2019 8-K/A Quarterly results
Docs: "Micron Solutions, Inc. Reports 2019 Second Quarter Results"
08/14/2019 8-K Quarterly results
Docs: "Micron Solutions, Inc. Reports 2019 Second Quarter Results",
"Micron Solutions, Inc. Reports 2019 Second Quarter Results"
05/15/2019 8-K Quarterly results
Docs: "First Quarter 2019 Review $ In thousands $ Change % Change Net sales $ 4,686 $ 5,119 $ -8.5% Gross profit $ 654 $ 731 $ -10.7% Gross margin 14.0% 14.3% Net loss $ $ $ Loss per share $ $ $ MICRON SOLUTIONS, INC. EBITDA RECONCILIATION Three Months Ended March 31, 2019 2018 Net loss $ $ Income tax benefit — — Other expense — Interest expense 111 97 Depreciation and amortization 375 396 Share-based compensation 58 34 Non-cash incentive plan accruals 50 — Non-recurring consulting and other expenses 128 12 Adjusted EBITDA $ 203 $ 349 Adjusted EBITDA margin % 4.3% 6.8% Non-GAAP Financial Measures In addition to reporting net loss, a U.S. generally accepted accounting principle measure, this news release contains information about Adjusted EBITDA , which is a non-GAAP measure. Share-based compens..."
03/19/2019 8-K Quarterly results
Docs: "MICRON SOLUTIONS, INC. EBITDA RECONCILIATION Three Months Ended Year Ended December 31, December 31, 2018 2017 2018 2017 Net loss $ $ $ $ Income tax benefit 2 2 Other expense — Interest expense 97 160 391 395 Depreciation and amortization 374 404 1,504 1,611 Share-based compensation 47 52 132 137 Non-recurring consulting and other expenses — 15 — 93 Adjusted EBITDA $ $ 266 $ 878 $ 823 Adjusted EBITDA margin % -9.1%"
11/13/2018 8-K Quarterly results
Docs: "MICRON SOLUTIONS, INC. EBITDA RECONCILIATION Three Months Ended Nine Months Ended September 30, September 30, 2018 2017 2018 2017 Net loss $ $ $ $ Other expense Interest expense 101 84 294 235 Depreciation and amortization 362 406 1,130 1,209 Share-based compensation 28 52 91 84 Non-recurring consulting and other expenses — — 20 — Adjusted EBITDA $ 401 $ 338 $ 1,279 $ 480 Adjusted EBITDA margin %"
08/14/2018 8-K Quarterly results
Docs: "MICRON SOLUTIONS, INC. EBITDA RECONCILIATION Three Months Ended Six Months Ended June, 30 June, 30 2018 2017 2018 2017 Net income $ 34 $ $ $ Other expense Interest expense 96 87 193 151 Depreciation and amortization 372 407 768 803 Share-based compensation 29 17 63 32 Non-recurring consulting and other expenses 8 — 20 — Adjusted EBITDA $ 527 $ $ 878 $ 142 Adjusted EBITDA margin % 9.9% -0.2%"
05/15/2018 8-K Quarterly results
Docs: "MICRON SOLUTIONS, INC. EBITDA RECONCILIATION Three Months Ended March 31, 2018 2017 Net loss $ $ Other expense Interest expense 97 64 Depreciation and amortization 396 396 Share-based compensation 34 26 Non-recurring consulting and other expenses 12 — Adjusted EBITDA $ 350 $ 248 Adjusted EBITDA margin %"
03/26/2018 8-K Quarterly results
Docs: "MICRON SOLUTIONS, INC. EBITDA RECONCILIATION Three Months Ended Year Ended December 31, December 31, 2017 2016 2017 2016 Net loss $ $ $ $ Income tax benefit — - Other expense — Interest expense 160 67 395 260 Depreciation and amortization 404 389 1,613 1,541 Share-based compensation 52 4 137 47 Non-recurring consulting and other expenses 15 — 93 — Adjusted EBITDA $ 266 $ 89 $ 825 $ 1,086 Adjusted EBITDA margin %"
11/13/2017 8-K Quarterly results
Docs: "MICRON SOLUTIONS, INC. ADJUSTED EBITDA RECONCILIATION Three Months Ended Nine Months Ended September September 2017 2016 2017 2016 Net loss $ $ $ $ Other expense — Interest expense 84 70 235 193 Depreciation and amortization 406 407 1,209 1,152 Share-based compensation 52 4 85 35 Non-recurring charges 78 — 78 — Adjusted EBITDA $ 416 $ 412 $ 558 $ 988 Adjusted EBITDA margin %"
08/11/2017 8-K Quarterly results
05/11/2017 8-K Quarterly results
Docs: "MICRON SOLUTIONS, INC. EBITDA RECONCILIATION Three Months Ended March 31, 2017 2016 Net loss $ $ Other expense Interest expense 64 60 Depreciation and amortization 396 361 Impairment of intangibles — 118 Share-based compensation 26 15 EBITDA $ 248 $ 169 EBITDA margin %"
03/22/2017 8-K Form 8-K - Current report
11/09/2016 8-K Form 8-K - Current report
08/11/2016 8-K Quarterly results
Docs: "ARRHYTHMIA RESEARCH TECHNOLOGY, INC. EBITDA RECONCILIATION      Three Months Ended Six Months Ended  June 30, June 30,  2016 2015 2016 2015 Net income from continuing operations $62 $115 Income tax provision",
"ARRHYTHMIA RESEARCH TECHNOLOGY, INC. EBITDA RECONCILIATION      Three Months Ended Six Months Ended  June 30, June 30,  2016 2015 2016 2015 Net income from continuing operations $62 $115 Income tax provision"
05/12/2016 8-K Form 8-K - Current report
03/10/2016 8-K Form 8-K - Current report
11/12/2015 8-K Quarterly results
Docs: "ARRHYTHMIA RESEARCH TECHNOLOGY, INC. EBITDA RECONCILIATION Three Months Ended Nine Months Ended September 30, September 30, 2015 2014 2015 2014 Net income from continuing operations $ $ 130 $ $ 629 Income tax provision"
08/13/2015 8-K Quarterly results
Docs: "1 Q2 2015 EARNINGS RELEASE"
05/13/2015 8-K Quarterly results
Docs: "Arrhythmia Research Technology, Inc. Reports First Quarter 2015 Results • First quarter net sales were $5.9 million • Generated $275 thousand of cash from operations in the first quarter FITCHBURG, MA, May 13, 2015 -- Arrhythmia Research Technology, Inc. , through its wholly-owned subsidiary, Micron Products, Inc., a diversified contract manufacturing organization that produces highly-engineered, innovative medical device technologies requiring precision machining and injection molding, announced today results for its first quarter ended March 31, 2015. Salvatore Emma, Jr., President and CEO, commented, "In the quarter, we reported a 25.6% increase in net sales of automotive and molded medical components, as well as a 19.7% increase in sensors’ sales volume. However, our operating results ..."
11/12/2014 8-K Quarterly results
Docs: "EXHIBIT"
08/07/2014 8-K Quarterly results
Docs: "EXHIBIT"
05/09/2014 8-K Quarterly results
Docs: "Arrhythmia Research Technology, Inc. Reports Earnings Per Share of $0.09 on 6.9% Increase in First Quarter 2014 Sales"
11/19/2013 8-K Quarterly results
Docs: "ARRHYTHMIA RESEARCH TECHNOLOGY, INC. ANNOUNCES THIRD QUARTER 2013 RESULTS Fitchburg, MA Arrhythmia Research Technology, Inc. and its subsidiaries announced today its results for the quarter ended September 30, 2013. The Company's financial results reflect the consolidated results of Arrhythmia Research Technology, Inc. and its subsidiaries, including Micron Products, Inc. , and the discontinued operations of RMDDxUSA Corp. and RMDDx Corporation . Quarter Ended The Company reported total consolidated revenue from continuing operations of $4,728,217 for the quarter ended September 30, 2013, compared to $4,959,034 for the quarter ended September 30, 2012, a decrease of $230,817 or 4.7%. Net loss from continuing operations for the quarter ended September 30, 2013 was $569,528, or $0.21 per sha..."
10/08/2013 8-K Form 8-K - Current report
11/27/2012 8-K Form 8-K - Current report
08/14/2012 8-K Form 8-K - Current report
05/18/2012 8-K Form 8-K - Current report
11/14/2011 8-K Form 8-K - Current report
08/15/2011 8-K Form 8-K - Current report
05/12/2011 8-K Form 8-K - Current report
03/22/2007 8-K Form 8-K - Current report
05/09/2006 8-K Form 8-K - Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy